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Abstract
Purpose. To investigate the correlation between single limb support (SLS) phase (% of gait cycle) and the Western Ontario
and McMaster University Osteoarthritis Index (WOMAC) questionnaire and Medical Outcomes Study 36-Item Short-
Form Health Survey (SF-36 Health Survey) in patients with knee osteoarthritis (OA).
Method. A prospective observational study was employed with 125 adults with bilateral medial compartment symptomatic
knee OA who underwent a physical and radiographic evaluation. Velocity, step length and SLS were assessed by a
computerised mat (GAITRite). Patients completed the WOMAC and SF-36 Health Survey questionnaires.
Results. Statistical analysis examined the correlations between SLS and both questionnaires, between Kellgren & Lawrence
(K&L) scores and both questionnaires and between SLS correlations and K&L correlations. We found signiﬁcantly stronger
correlations between SLS and WOMAC-pain, WOMAC-function, the SF-36 pain sub-category, velocity and step length
than between K&L scores and these parameters (Pearson’s r¼0.50 vs. 0.26, 0.53 vs. 0.34, 0.50 vs. 023, 0.81 vs. 0.33, 0.77
vs. 0.37, respectively; all p50.05). Signiﬁcant differences in SLS were found over WOMAC-pain, WOMAC-function and
SF-36 overall score quartiles (p50.05 for all).
Conclusion. We recommend integrating SLS as an objective parameter in the comprehensive evaluation of patients with
knee OA.
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Introduction
In order to understand and assess the symptoms and
functional severity of patients suffering from knee
osteoarthritis (OA), clinicians and researchers use
validated self-evaluation questionnaires such as the
Western Ontario and McMaster Universities Os-
teoarthritis Index (WOMAC) and the Medical Out-
comes Study 36-Item Short-Form Health Survey
(SF-36 Health Survey) [1,2]. Nevertheless, there is a
lack in accurate, objective, non-invasive and simple
clinical tools for assessing knee OA in terms of
functional independence and performance.
In recent years, researchers have gained an
increased understanding of important biomechanical
gait pattern changes that occur during the pathogen-
esis and progression of knee OA [3–5]. Studies
comparing the gait spatio-temporal parameters of
patients with knee OA with those of healthy indivi-
duals have shown that patients with knee OA tend to
have a slower walking speed, shorter step length and
shorter single limb support (SLS) [4,6,7].
The SLS value is a percent of the gait cycle that
corresponds to the time spent on one limb while the
contralateral limb swings forward. In healthy popula-
tions, this phase accounts for 38–40% of the gait
cycle [8]. While a relationship has yet to be clearly
established between decreased loads due to pain and
decreased SLS values, studies have shown that
patients with knee OA attempt to avoid pain by
decreasing loads from the affected joint [9]. A patient
can achieve this by decreasing the SLS phase and
increasing the double limb support (DLS) phase. A
valid assumption is, therefore, that patients with knee
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trying to alleviate their pain. The same may be true for
walking speed and stride length. We have shown in a
previous study, however, that while walking speed is a
parameter that can be consciously controlled by the
patient, the SLS is less sensitive [10].
In order to conﬁrm whether this is a valid and
feasible parameter for clinical assessment of knee OA,
SLS must ﬁrst be compared to the gold standard
questionnaires currently being used for evaluating
knee OA. The purpose of this study was to examine
the correlation between the SLS phase and the
WOMAC questionnaire and SF-36 Health Survey.
Methods
Study participants
This was a prospective observational study on 125
patients with bilateral medial compartment knee
OA. Patients were recruited to the study from the
Orthopaedic Outpatient Clinic at Assaf Harofeh
Medical Centre in Zeriﬁn, Israel during their routine
quarterly examination. Patients were also recruited
from AposTherapy Centre in Herzliya, Israel during
their ﬁrst visit to the clinic. Patients arrived for the
ﬁrst visit at the hospital or clinic due to complaints of
knee pain. The protocol was approved by Assaf
Harofeh Medical Centre Institutional Helsinki Com-
mittee Registry (Helsinki registration number 185/
07, NIH protocol no. NCT00599729). All patients
volunteered and gave written informed consent
before entering the study.
Eligibility was deﬁned as having symptomatic knee
OA for at least 6 months, fulﬁlling the ACR clinical
criteria for OA of the knee [11], and having radio-
graphically assessed OA of the knee according to the
K&L scale [12]. Exclusion criteria were acute septic
arthritis, inﬂammatory arthritis and corticosteroid
injection within 3 months of the study, avascular
necrosis, history of knee buckling or recent knee
injury, joint replacement, neuropathic arthropathy,
increased tendency to fall due to neurological dis-
orders, lack of physical or mental ability to perform
or comply with the study procedure, and history of
pathological osteoporotic fracture. Patients were
examined by an orthopaedic surgeon at each site to
determine eligibility.
Protocol
All patients were radiographically assessed based on
their most recently available radiograph by the senior
author (N.H.) using the K&L scale. The senior author
was blinded to the data collection process (gait analysis
and questionnaires). The radiographs were obtained
using a standardised technique [13]. Brieﬂy, the
images were 458 posteroanterior ﬂexion weight-bear-
ing radiographs. Patients were instructed to ﬂex both
k n e e st o4 5 8 and make an effort to distribute their
weight evenly on the two extremities. Toes were
pointed straight ahead and the patellae touched the
ﬁlm cassette. The radiographic machine was posi-
tioned 101.6 cm away from the cassette. While all
patients had lateral view radiographs, the K&L scoring
was conducted on the tibio-femoral joint since this
was the most symptomatic area in all patients. In
addition, patients underwent a physical examination
and anthropometric measurements of height, weight
and leg length (measured from the tip of the greater
trochanter to the ﬂoor through the lateral melleolus in
an upright standing position) [14]. The gait spatio-
temporal parameters were measured with a compu-
terised walkway system (GAITRite, CIR Systems
Inc.). The computerised system is an electronic
walkway mat 4.87 m long. The spatio-temporal para-
meters are measured, processed and stored on a PC
computer running the GAITRite Platinum software
(version 3.9). Patients were instructed to walk barefoot
at a self-selected speed since previous studies have
shown that this speed gives consistent gait parameters
results [15,16]. Patients were instructed to walk 3 m
before and after the walkway mat to allow sufﬁcient
acceleration and deceleration time outside the mea-
surement area. Each gait test included six walks and
the mean value of the six walks was calculated for each
parameter. Following the gait test patients completed
the WOMAC questionnaire and the SF-36 Health
Survey.Sincethegait test onlytakes3 min to complete
it isreasonable to assume that no fatigue willoccurthat
could affect the results of the questionnaires.
A valid Hebrew translation of the WOMAC Index
VAS scale questionnaire was used (version 3.1) [17].
Results range from 0 cm–10 cm, where 0 indicates
no pain, stiffness and functional limitation and 10
indicates severe pain, stiffness and functional limita-
tion. A valid Hebrew translation of the SF-36
original Likert scale was used [18]. The results range
between 0 and 100, where 0 indicates poor quality of
life and 100 indicates excellent quality of life.
The following parameters were evaluated: radio-
graphic assessment according to K&L grading
scale, SLS (% gait cycle), gait velocity (cm/s), step
length (cm), WOMAC-pain, WOMAC-function and
quality of life using the SF-36 Health Survey sub-
categories.
Statistical analysis
For each patient, the leg with the lowest mean
SLS value was chosen for comparison to the
1104 R. Debi et al.questionnaire data and this value was used for all
analyses. SLS represents the phase in the gait cycle
when the body weight is entirely supported by one
limb while the contralateral limb swings forward.
Therefore, we assumed that the knee with the lowest
SLS value would have greater difﬁculty bearing
loads. The K&L data for this same leg were also
used for comparison to the questionnaire data. Data
were analysed using SPSS statistic software (version
17.0). The distributions of gait characteristics were
examined using the Kolmogorov–Smirnov non-
parametric test. Descriptive statistics were calculated
for all continuous parameters. Pearson correlations
and 95% conﬁdence intervals for the correlation
coefﬁcients were calculated in order to demonstrate
the correlation between WOMAC-pain, WOMAC-
function and SF-36 scales and measures of knee OA
severity (K&L and SLS). Values of r 0.25 were
considered low, values of 0.255r 0.50 were
considered moderate and values of r 0.75 were
considered high [19]. Comparisons between the
correlation coefﬁcients of the questionnaires (WO-
MAC-pain, WOMAC-function and SF-36 scales) to
SLS and to K&L were conducted according to Meng
et al. [20]. SLS means were compared over quartiles
of the WOMAC scores using the one way analysis of
variance (ANOVA) test. Differences in SLS medians
were demonstrated in box plots. All statistical tests
were two-sided. The level of signiﬁcance for all
statistical tests was set at p50.05.
Results
Patient characteristics are presented in Table I. Gait
velocity and step length were normalised to leg
length in order to eliminate the effect of leg length on
these parameters [21]. While preferable in analysis,
these normalised values did not affect the correlation
results. Results of the spatio-temporal parameters
and the questionnaires scores are summarised in
Tables II and III, respectively.
The correlations between the K&L score and
WOMAC-pain, WOMAC-function and SF-36 sub-
categories were low to moderate, while the correla-
tions between the SLS and the questionnaires were
moderate. The correlations between SLS and the
questionnaires were signiﬁcantly stronger than the
correlations between the K&L and the question-
naires. High correlations were also found between
SLS and both normalised velocity and normalised
step length. All correlation results are summarised in
Table IV.
We further investigated the mean SLS value in
WOMAC-pain, WOMAC-function and SF-36 over-
all score (Tables V–VII). It can be seen that as the
level of pain and functional limitation increases, the





Male gender 46 37
Age (years) 65.9 11.2
Height (cm) 160 8.7





Left leg length (cm) 83.0 5.9
Right leg length (cm) 82.9 5.8
K&L* Scale Grade 1 26 20.8
K&L Scale Grade 2 32 25.6
K&L Scale Grade 3 35 28
K&L Scale Grade 4 32 25.6
*Kellgren & Lawrence.
Table II. Spatio-temporal parameters measured by gait analysis.
Parameter Minimum Maximum Mean (SD)
Velocity (cm/s) 25.8 147.9 94.3 (23.0)
Normalised velocity
(cm/s/leg length)
0.33 1.73 1.13 (0.3)
Cadence (steps/min) 65.8 131.3 105.3 (12.6)
Step length left (cm) 21.1 77.3 52.9 (9.3)
Step length right (cm) 19.1 76.2 53.4 (9.3)
Normalised step length
left (cm/leg length)
0.27 0.86 0.63 (0.1)
Normalised step length
right (cm/leg length)
0.25 0.88 0.64 (0.1)
Single limb support left
(% gait cycle)
24.0 42.4 36.5 (3.3)
Single limb support right
(% gait cycle)
25.0 42.9 36.9 (3.1)
Table III. WOMAC osteoarthritis index and SF-36 health survey
scores.
Parameter Minimum Maximum Mean (SD)
WOMAC
Pain 0 9.6 4.4 (2.6)
Function 0 9.6 4.4 (2.7)
SF-36
Physical functioning 0 100 46.4 (25.4)
Role limitation due to
physical health
0 100 47 (40.6)
Role limitation due to
emotional problems
0 100 63.9 (41)
Energy/fatigue 0 100 55.4 (22.0)
Emotional well being 12 100 70.3 (18.3)
Social functioning 0 100 73.5 (25.7)
Pain 0 100 46.3 (26.3)
General health 12.5 91.7 58.6 (16.9)
SLS correlates with functional severity 1105mean SLS decreases (all p50.05). Additionally, as
the quality of life increases (SF-36 overall score), the
mean SLS increases (p50.05). This relationship is
further illustrated in the box plots showing the
median SLS in WOMAC-pain (Figure 1a), WO-
MAC-function (Figure 1b) and SF-36 overall score
quartiles (Figure 1c). This distribution in the quartile
categories further elucidates the correlations re-
ported above.
Discussion
The purpose of this study was to examine the
correlation of an objective gait parameter with the
level of pain and function and with the quality of life
perception of patients suffering from knee OA. Since
the ability of the radiographic assessment to reﬂect
the functional and dynamic condition of patients
with knee OA is limited, we found it important to
add an objective, non-invasive parameter that will
help evaluate the functional severity of knee OA.
The gait pattern differences between healthy
individuals and patients with knee OA illustrate the
impact of the disease on mobility parameters [6].
Speciﬁcally, Brandes et al. reported lower SLS values
in both limbs among patients with knee OA
compared to SLS values of healthy individuals [7].
Table IV. Correlation between the WOMAC-pain, WOMAC-function, SF-36 sub-categories, normalised velocity, normalised step length
parameters and both K&L scale and SLS.
Parameter K&L
{ Grading Scale (0–4), r
{ 95% CI Single limb support, r
{ 95% CI p*
WOMAC
x
Pain 0.26 0.07–0.4 70.50 70.62 to 70.35 0.01
Function 0.34 0.17–0.48 70.53 70.63 to 70.37 0.03
SF-36
{
Physical functioning 70.39 70.53 to 70.23 0.49 0.34–0.61 0.25
Energy/fatigue 70.15** 70.32 to –0.03 0.33 0.16–0.48 0.06
Pain 70.23 70.39 to 70.06 0.50 0.36–0.62  0.01
General health 70.21 70.37 to 70.04 0.36 0.20–0.50 0.12
Normalised velocity 70.33 70.48 to 70.16 0.81 0.74–0.86 50.01
Normalised step length 70.37 70.51 to 70.21 0.77 0.69–0.83 50.01
*p values refer to signiﬁcant differences between Pearson correlation coefﬁcients of the questionnaires to SLS and to K&L according to the
method of Meng et al.
**Not statistically signiﬁcant (p¼0.154).
{Kellgren and Lawrence.
{r¼Pearson correlation coefﬁcient.
xWestern Ontario and McMaster University Osteoarthritis Index.
{Medical outcomes study 36-item short-form health survey.
Table V. Distribution of mean SLS values over WOMAC-pain
quartiles.
WOMAC*-pain (cm) quartiles
Q1 Q2 Q3 Q4
 2.1 2.1–4.5 4.5–6.2  6.2
SLS
{ (%)
{ 37.7 36.1 35.5 33.4
95% C.I. 37.0–38.5 35.1–37.1 34.5–36.5 32.0–34.7
*Western Ontario and McMaster University Osteoarthritis Index.
{Single limb support.
{One-way ANOVA test. Signiﬁcance level was set at p50.05.
Signiﬁcant differences in SLS were found over the quartiles.
Table VI. Distribution of mean SLS values over WOMAC-
function quartiles.
WOMAC*-function (cm) quartiles
Q1 Q2 Q3 Q4
 2.3 2.3–4.4 4.4–6.5  6.5
SLS
{ (%)
{ 37.9 36.4 34.6 33.8
95% C.I. 37.2–38.7 35.5–37.3 33.7–35.4 32.3–35.2
{Western Ontario and McMaster University Osteoarthritis Index.
{Single limb support.
{One-way ANOVA test. Signiﬁcance level was set at p50.05.
Signiﬁcant differences in SLS were found over the quartiles.
Table VII. Distribution of mean SLS values over SF-36 overall
score quartiles.
SF-36* Overall Score quartiles
Q1 Q2 Q3 Q4
 40 40–55 55–71  71
SLS
{ (%)
{ 32.9 35.4 36.8 37.7
95% C.I. 31.6–34.2 34.4–36.3 35.8–37.8 37.0–38.4
*Medical outcomes study 36-item short-form health survey.
{Single limb support.
{One-way ANOVA test. Signiﬁcance level was set at p50.05.
Signiﬁcant differences in SLS were found over the quartiles.




































































































































































































SLS correlates with functional severity 1107We assumed that patients with severe pain and
functional limitation will have lower SLS values,
whereas patients with minimal pain and functional
limitation will demonstrate higher SLS values. The
current study found moderate correlations between
the SLS parameter and the WOMAC-pain, WO-
MAC-function and the sub-categories of the SF-36
Health Survey questionnaires. When examining the
correlation between two independent variables (SLS
and WOMAC-pain) that reﬂect OA severity from a
different perspective it is expected that a moderate
correlation can be considered to be a good correla-
tion. In contrast, the correlation between two
identical measurements (i.e. two different blood
pressure gauges) that measure the same parameter
would be expected to be much higher.
These results indicate that SLS can express the
level of pain and functional limitation of patients
with knee OA and may also reﬂect a patient’s
functional condition during different daily tasks.
SLS may, therefore, be a helpful tool for examining
knee OA functional severity clinically. Evaluations of
structural severity, however, such as a K&L assess-
ment, are still important in examining knee OA.
Future studies should further examine the role of
SLS as a clinical objective indicator for the severity of
knee OA.
Previous studies have reported that patients with
knee OA walk slower and have a shorter step
length compared to healthy age-matched individuals
[6,7]. It may, therefore, seem that simple gait tests
monitoring gait velocity, such as ‘time up and go’
tests, are enough to evaluate a patient’s functional
ability. But as with self-evaluation questionnaires,
such tests do not have independency since patients
can consciously control their gait velocity and step
length. SLS on the other hand is less sensitive to
changes and is probably more difﬁcult for the patient
to voluntarily control [10].
This study had limitations with regard to the study
population. Only patients with clinical and radio-
graphic knee OA were included in this study [11]. It
would have been preferable to recruit patients
experiencing knee pain and functional limitations
that do not have radiographic evidence of knee OA.
Examining the correlations between SLS and pain,
function and quality of life in patients reporting knee
pain without radiographic symptoms might help in
identifying early stages of knee OA disease that are
not yet reﬂected in radiographic evaluation. For this
reason our analysis of SLS as a functional severity
assessment tool is limited only to patients having
structural OA deformities.
The ﬁndings of this study suggest that inclusion of
an objective measurement tool such as spatio-
temporal parameters and particularly SLS can help
in evaluating knee OA severity, effectiveness of
treatment and might even help in disease manage-
ment. Furthermore, SLS may serve as a simple
follow-up measurement in patients already diag-
nosed with and in those being treated for knee OA
and other disorders. A medical practitioner may,
therefore, ﬁnd it beneﬁcial to send patients for
inexpensive gait.
Conclusions
SLS correlated with WOMAC-pain, WOMAC-
function, SF-36, velocity and step length. We found
stronger correlations between SLS and WOMAC-
pain, WOMAC-function and SF-36 pain than
between K&L scores and these parameters. There-
fore, we recommend integrating the SLS as an
objective parameter in the comprehensive evaluation
of a patient with knee OA. Further investigation
is needed regarding the use of SLS as a clinical
indicator for the functional severity of knee OA.
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